V. Edeline

发表

Development and application of a real-time on-line blinded independent central review of interim PET scans to determine treatment allocation in lymphoma trials.

J. Raemaekers, M. Federico, N. Mounier, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation of early metastatic response by 123I-metaiodobenzylguanidine scintigraphy with overall response and event-free survival in stage IV neuroblastoma.

Bernard Asselain, Olivier Hartmann, K. Matthay, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Correlation o f E arly M etastatic R esponse b y 123 I-Metaiodobenzyl guanidine S cintigraphy W ith O verall Response a nd E vent-Free S urvival i n S tage I V N euroblastoma

K. Matthay, B. Asselain, J. Zucker, 2003 .

Metaiodobenzylguanidine assessment of metastatic neuroblastoma: observer dependency and chemosensitivity evaluation. The SFOP Group.

D. Frappaz, V. Edeline, F. Giammarile, 2000, Medical and pediatric oncology.

Randomized Phase III Study Comparing an Early PET Driven Treatment De-Escalation to a Not PET-Monitored Strategy in Patients with Advanced Stages Hodgkin Lymphoma: Interim Analysis of the AHL2011 Lysa Study

G. Salles, R. Bouabdallah, A. Stamatoullas, 2015 .

Multimodality imaging using PET/CT (18F)-fluorodeoxyglucose for radiotherapy field delineation of localized Hodgkin lymphoma.

V. Remouchamps, V. Edeline, T. Vander Borght, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Classical Hodgkin’s lymphoma: the Lymphoma Study Association guidelines for relapsed and refractory adult patients eligible for transplant

A. Stamatoullas, O. Casasnovas, E. W. Van Den Neste, 2013, Haematologica.

Positron Emission Tomography–Driven Strategy in Advanced Hodgkin Lymphoma: Prolonged Follow-Up of the AHL2011 Phase III Lymphoma Study Association Study

R. Bouabdallah, A. Stamatoullas, P. Feugier, 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Role of FDG-PET in the implementation of involved-node radiation therapy for Hodgkin lymphoma patients.

V. Edeline, A. Aupérin, V. Ribrag, 2014, International journal of radiation oncology, biology, physics.

The conundrum of Hodgkin lymphoma nodes: to be or not to be included in the involved node radiation fields. The EORTC-GELA lymphoma group guidelines.

E. Noordijk, L. Specht, Y. Lievens, 2008, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Use of FDG-PET/CT for systemic assessment of suspected primary central nervous system lymphoma: a LOC study

K. Hoang-Xuan, M. Habert, K. Mokhtari, 2020, Journal of Neuro-Oncology.

Early Positron Emission Tomography Response-Adapted Treatment in Stage I and II Hodgkin Lymphoma: Final Results of the Randomized EORTC/LYSA/FIL H10 Trial.

J. Raemaekers, R. Bouabdallah, A. Stamatoullas, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

PET-Guided Strategy Improves the Safety of Beacopp-Based Treatment in Advanced Hodgkin Lymphoma: Prolonged Follow-up of the Lysa Ahl 2011 Phase 3 Study

R. Bouabdallah, O. Casasnovas, P. Feugier, 2020 .

Final results of brentuximab vedotin combined with ifosfamide-carboplatin-etoposide in first refractory/relapsed Hodgkin lymphoma: a lymphoma study association phase I/II study

A. Stamatoullas, P. Feugier, M. André, 2022, Leukemia & lymphoma.

Prospective study of 18F-FDG PET in pediatric mediastinal lymphoma: A single center experience

H. Brisse, S. Neuenschwander, V. Edeline, 2007, Leukemia & lymphoma.

Baseline total metabolic volume (TMTV) to predict the outcome of patients with advanced Hodgkin lymphoma (HL) enrolled in the AHL2011 LYSA trial.

G. Salles, R. Bouabdallah, A. Stamatoullas, 2016 .

(18)F-FDG PET and CT-scan Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti-PD1 Immune Checkpoint Inhibitor

Lawrence H. Schwartz, Roch Houot, Laurent Dercle, 2018 .

Prospective study of bone marrow infiltration in aggressive lymphoma by three independent methods: whole-body MRI, PET/CT and bone marrow biopsy.

M. Schlumberger, D. Vanel, J. Bosq, 2008, European journal of radiology.

PET-adapted treatment for newly diagnosed advanced Hodgkin lymphoma (AHL2011): a randomised, multicentre, non-inferiority, phase 3 study.

R. Bouabdallah, A. Stamatoullas, P. Feugier, 2019, The Lancet. Oncology.

18F-FDG PET/CT imaging versus dynamic contrast-enhanced CT for staging and prognosis of inflammatory breast cancer

V. Edeline, D. Bellet, A. Giraudet, 2013, European Journal of Nuclear Medicine and Molecular Imaging.

Single photon emission tomography/computed tomography (SPET/CT) and positron emission tomography/computed tomography (PET/CT) to image cancer

V. Edeline, D. Bellet, A. Giraudet, 2011, Journal of surgical oncology.

Role of FDG PET-CT in the treatment management of Hodgkin lymphoma.

O. Casasnovas, V. Edeline, T. Vander Borght, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Central nervous system metastases in neuroblastoma

H. Brisse, K. Matthay, J. Lumbroso, 2003, Cancer.

Assessment of response to endocrine therapy using FDG PET/CT in metastatic breast cancer: a pilot study

V. Edeline, D. Bellet, A. Giraudet, 2012, European Journal of Nuclear Medicine and Molecular Imaging.

Breast cancer recurrence diagnosis suspected on tumor marker rising

E. Brain, V. Edeline, D. Bellet, 2011, Cancer.

Relationship between lymphoscintigraphy and clinical findings in lower limb lymphedema (LO): toward a comprehensive staging.

V. Edeline, A. Pecking, J. Alberini, 2008, Lymphology.

Brentuximab Vedotin in First Refractory/Relapsed Classical Hodgkin Lymphoma Patients Treated By Chemotherapy (ICE) before Autologous Transplantation. Final Analysis of Phase II Study

A. Stamatoullas, V. Edeline, V. Ribrag, 2019, Blood.

Contribution of PET/CT In the Design of the Involved Node Radiotherapy (INRT) Concept for Patients with Localized Hodgkin Lymphoma: Preliminary Results on 117 Patients.

V. Edeline, A. Aupérin, V. Ribrag, 2010 .

Molecular Imaging of Neuroendocrine Cancer by Fusion SPET/CT

V. Edeline, D. Bellet, A. Pecking, 2009 .

Total Metabolic Tumor Volume and Tumor Dissemination Are Independent Prognostic Factors in Advanced Hodgkin Lymphoma

R. Bouabdallah, M. André, M. Meignan, 2021, Blood.

Nivolumab First-Line Therapy for Elderly, Frail Hodgkin Lymphoma Patients: Niviniho, a Lysa Phase II Study

P. Feugier, M. André, E. Durot, 2021, Blood.

18F-FDG PET and CT Scans Detect New Imaging Patterns of Response and Progression in Patients with Hodgkin Lymphoma Treated by Anti–Programmed Death 1 Immune Checkpoint Inhibitor

R. Houot, L. Schwartz, L. Dercle, 2018, The Journal of Nuclear Medicine.

[18F]FDG PET-MRI provides survival biomarkers in primary central nervous system lymphoma in the elderly: an ancillary study from the BLOCAGE trial of the LOC network

K. Hoang-Xuan, D. Galanaud, M. Soret, 2023, European Journal of Nuclear Medicine and Molecular Imaging.